Article
B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients
8 Mar 2022
Abstract excerpt
To elucidate cross-sectional patterns and longitudinal changes of oral and stool microbiota in multiple sclerosis (MS) patients and the effect of B-cell depletion. We conducted an observational, longitudinal clinical cohort study analysing four timepoints over 12 months in 36 MS patients, of whom 22 initiated B-cell depleting therapy with ocrelizumab and a healthy control group. For microbiota analysis of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
